Literature DB >> 23303738

2-Carbaborane-3-phenyl-1H-indoles--synthesis via McMurry reaction and cyclooxygenase (COX) inhibition activity.

Markus Laube1, Wilma Neumann, Matthias Scholz, Peter Lönnecke, Brenda Crews, Lawrence J Marnett, Jens Pietzsch, Torsten Kniess, Evamarie Hey-Hawkins.   

Abstract

Cyclooxygenase-2 (COX-2) inhibitors have been the focus of medicinal chemistry efforts for years, and many compounds that exhibit high selectivity and affinity have been developed. As carbaboranes represent interesting pharmacophores as phenyl mimetics in drug development, this paper presents the synthesis of carbaboranyl derivatives of COX-2-selective 2,3-disubstituted indoles. Despite the lability of carbaboranes under reducing conditions, 2-carbaborane-3-phenyl-1H-indoles could be synthesized by McMurry cyclization of the corresponding amides. Whereas the meta-carbaboranyl-substituted derivatives lacked COX inhibitory activity, an ortho-carbaboranyl analogue was active, but showed a selectivity shift toward COX-1.
Copyright © 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23303738      PMCID: PMC3849512          DOI: 10.1002/cmdc.201200455

Source DB:  PubMed          Journal:  ChemMedChem        ISSN: 1860-7179            Impact factor:   3.466


  32 in total

1.  Design and synthesis of 4-azaindoles as inhibitors of p38 MAP kinase.

Authors:  Alejandra Trejo; Humberto Arzeno; Michelle Browner; Sushmita Chanda; Soan Cheng; Daniel D Comer; Stacie A Dalrymple; Pete Dunten; JoAnn Lafargue; Brett Lovejoy; Jose Freire-Moar; Julie Lim; Joel Mcintosh; Jennifer Miller; Eva Papp; Deborah Reuter; Rick Roberts; Florentino Sanpablo; John Saunders; Kyung Song; Armando Villasenor; Stephen D Warren; Mary Welch; Paul Weller; Phyllis E Whiteley; Lu Zeng; David M Goldstein
Journal:  J Med Chem       Date:  2003-10-23       Impact factor: 7.446

Review 2.  Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition.

Authors:  Daniel L Simmons; Regina M Botting; Timothy Hla
Journal:  Pharmacol Rev       Date:  2004-09       Impact factor: 25.468

3.  Selective visualization of cyclooxygenase-2 in inflammation and cancer by targeted fluorescent imaging agents.

Authors:  Md Jashim Uddin; Brenda C Crews; Anna L Blobaum; Philip J Kingsley; D Lee Gorden; J Oliver McIntyre; Lynn M Matrisian; Kotha Subbaramaiah; Andrew J Dannenberg; David W Piston; Lawrence J Marnett
Journal:  Cancer Res       Date:  2010-05-01       Impact factor: 12.701

4.  Synthesis and biological evaluation of substituted 2-sulfonyl-phenyl-3-phenyl-indoles: a new series of selective COX-2 inhibitors.

Authors:  Wenhui Hu; Zongru Guo; Fengming Chu; Aiping Bai; Xiang Yi; Guifang Cheng; Jing Li
Journal:  Bioorg Med Chem       Date:  2003-04-03       Impact factor: 3.641

5.  4-Aryl/cycloalkyl-5-phenyloxazole derivatives as selective COX-2 inhibitors.

Authors:  Hiromasa Hashimoto; Kimiya Maeda; Koichi Ozawa; Jun-ichi Haruta; Korekiyo Wakitani
Journal:  Bioorg Med Chem Lett       Date:  2002-01-07       Impact factor: 2.823

Review 6.  Cyclooxygenase-2 inhibitors: a literature and patent review (2009 - 2010).

Authors:  Baker Jawabrah Al-Hourani; Sai Kiran Sharma; Mavanur Suresh; Frank Wuest
Journal:  Expert Opin Ther Pat       Date:  2011-06-29       Impact factor: 6.674

Review 7.  Cyclooxygenase in biology and disease.

Authors:  R N Dubois; S B Abramson; L Crofford; R A Gupta; L S Simon; L B Van De Putte; P E Lipsky
Journal:  FASEB J       Date:  1998-09       Impact factor: 5.191

8.  Fluorinated COX-2 inhibitors as agents in PET imaging of inflammation and cancer.

Authors:  Md Jashim Uddin; Brenda C Crews; Kebreab Ghebreselasie; Imran Huda; Philip J Kingsley; Mohammad Sib Ansari; Mohammed N Tantawy; Jeffery Reese; Lawrence J Marnett
Journal:  Cancer Prev Res (Phila)       Date:  2011-09-07

9.  Carbaboranes as pharmacophores: similarities and differences between aspirin and asborin.

Authors:  Matthias Scholz; Goran N Kaluđerović; Harish Kommera; Reinhard Paschke; Joanna Will; William S Sheldrick; Evamarie Hey-Hawkins
Journal:  Eur J Med Chem       Date:  2011-01-28       Impact factor: 6.514

10.  Incorporation of ortho-carbaboranyl-Nε-modified L-lysine into neuropeptide Y receptor Y1- and Y2-selective analogues.

Authors:  Verena M Ahrens; René Frank; Sven Stadlbauer; Annette G Beck-Sickinger; Evamarie Hey-Hawkins
Journal:  J Med Chem       Date:  2011-03-11       Impact factor: 7.446

View more
  4 in total

1.  nido-Dicarbaborate Induces Potent and Selective Inhibition of Cyclooxygenase-2.

Authors:  Wilma Neumann; Shu Xu; Menyhárt B Sárosi; Matthias S Scholz; Brenda C Crews; Kebreab Ghebreselasie; Surajit Banerjee; Lawrence J Marnett; Evamarie Hey-Hawkins
Journal:  ChemMedChem       Date:  2015-06-18       Impact factor: 3.466

Review 2.  Development of Antioxidant COX-2 Inhibitors as Radioprotective Agents for Radiation Therapy-A Hypothesis-Driven Review.

Authors:  Markus Laube; Torsten Kniess; Jens Pietzsch
Journal:  Antioxidants (Basel)       Date:  2016-04-19

3.  Carboranyl Analogues of Mefenamic Acid and Their Biological Evaluation.

Authors:  Liridona Useini; Marija Mojić; Markus Laube; Peter Lönnecke; Jonas Dahme; Menyhárt B Sárosi; Sanja Mijatović; Danijela Maksimović-Ivanić; Jens Pietzsch; Evamarie Hey-Hawkins
Journal:  ACS Omega       Date:  2022-06-29

4.  Carboranyl Derivatives of Rofecoxib with Cytostatic Activity against Human Melanoma and Colon Cancer Cells.

Authors:  Antonio Buzharevski; Svetlana Paskaš; Menyhárt-Botond Sárosi; Markus Laube; Peter Lönnecke; Wilma Neumann; Blagoje Murganić; Sanja Mijatović; Danijelа Maksimović-Ivanić; Jens Pietzsch; Evamarie Hey-Hawkins
Journal:  Sci Rep       Date:  2020-03-16       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.